Literature DB >> 7484577

Hepatic involvement in Osler-Weber-Rendu disease: findings on pulsed and color Doppler sonography.

H Naganuma1, H Ishida, M Niizawa, K Igarashi, T Shioya, O Masamune.   

Abstract

OBJECTIVE: The purpose of this study was to compare the hemodynamics of the liver vasculature as determined by Doppler sonography for patients with Osler-Weber-Rendu disease and for healthy subjects. SUBJECTS AND METHODS: Real-time color Doppler sonography and pulsed Doppler sonography were used to study 10 patients with Osler-Weber-Rendu disease and 25 healthy subjects. Vessel diameter and flow velocity in the hepatic artery and its branches as well as in the portal vein and its segmental branches were determined. Flow patterns in the hepatic veins were analyzed. The clinical manifestations of the disease were correlated with the Doppler sonographic findings.
RESULTS: The hepatic artery and its branches were dilated and tortuous, and flow velocity was greater in patients than in healthy subjects; hepatic artery velocities (mean +/- SD) were 153 +/- 65.2 cm/sec versus 64.9 +/- 11.4 cm/sec (p < .005). The resistive index measured in the hepatic artery did not differ significantly between the two groups (p was not significant). No intrahepatic arteriovenous shunt sites were detected by color Doppler sonography. However, arterioportal shunts were observed in two patients, one of whom also had a portovenous shunt. A portovenous shunt and multiple shunts between hepatic veins were found in another patient. Portal venous flow was similar in both groups. No relationship between Doppler sonographic changes and clinical manifestations was found.
CONCLUSION: The multiple microscopic arteriovenous shunts found in Osler-Weber-Rendu disease were not detected in our patients but resulted in dilatation and increased flow velocity in the hepatic artery. Flow velocity in the portal vein appeared to be undisturbed. Large intrahepatic shunts were easily outlined by Doppler sonography.

Entities:  

Mesh:

Year:  1995        PMID: 7484577     DOI: 10.2214/ajr.165.6.7484577

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

1.  Abnormal pulmonary density discovered on routine chest radiograph.

Authors:  A B Small
Journal:  Proc (Bayl Univ Med Cent)       Date:  2001-01

2.  [Recurring nose bleeds, dyspnea and conspicuous findings in the lung and liver].

Authors:  K Holzapfel; N von Beckerath; E J Rummeny; J Gaa
Journal:  Radiologe       Date:  2007-08       Impact factor: 0.635

Review 3.  [Acute hepatic vascular complications].

Authors:  A Ochs
Journal:  Internist (Berl)       Date:  2011-07       Impact factor: 0.743

4.  Hemodynamic effect of the left gastric artery on esophageal varices in patients with cirrhosis.

Authors:  Soichiro Kiyono; Hitoshi Maruyama; Takayuki Kondo; Tadashi Sekimoto; Taro Shimada; Masanori Takahashi; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2016-01-18       Impact factor: 7.527

5.  Giant arteriovenous malformation located on the chest wall - diagnosis and endovascular treatment: report of a case.

Authors:  Sevda Yilmaz; Cansel Atinkaya; Aykut Aktas; Bora Peynircioglu
Journal:  Surg Today       Date:  2010-11-26       Impact factor: 2.549

6.  Intrahepatic porto-hepatic venous shunts in Rendu-Osler-Weber disease: imaging demonstration.

Authors:  Shunro Matsumoto; Hiromu Mori; Yasunari Yamada; Tomoko Hayashida; Yuzo Hori; Hiro Kiyosue
Journal:  Eur Radiol       Date:  2003-09-20       Impact factor: 5.315

7.  Treatment of high output cardiac failure by flow-adapted hepatic artery banding (FHAB) in patients with hereditary hemorrhagic telangiectasia.

Authors:  A Koscielny; W A Willinek; A Hirner; M Wolff
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

Review 8.  Diagnostic imaging in the study of visceral involvement of hereditary haemorrhagic telangiectasia.

Authors:  M Memeo; A Scardapane; R De Blasi; C Sabbà; A Carella; G Angelelli
Journal:  Radiol Med       Date:  2008-05-13       Impact factor: 3.469

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.